Accepted (ET)
7:06 PM
Aug 26, 2026
Filed
Aug 26, 2026
Documents
1
Size
6.8 KB
Summary
SI-BONE (SIBN) CEO Laura Francis Sells 25,972 Shares
What Happened
Laura Francis, CEO of SI‑BONE (SIBN), sold 25,972 shares on August 24, 2026 in open‑market transactions. The weighted‑average sale price was $20.12, producing proceeds of approximately $522,596. The sales were executed under a 10b5‑1 trading plan dated May 21, 2026 and occurred in multiple trades at prices ranging from $20.00 to $20.24.
Key Details
- Transaction date: 2026-08-24 (Form 4 filed 2026-08-26) — appears to be filed timely.
- Transaction type: Sale (open market) effected pursuant to a 10b5‑1 plan (F1).
- Shares sold: 25,972; weighted-average price: $20.12; price range: $20.00–$20.24 (F2).
- Proceeds: ~$522,596.
- Post‑sale holdings: The filing notes holdings include shares held by The David & Laura Joint Rev Tr (F3) and 355,697 shares issuable on settlement of restricted stock units (RSUs) granted to the reporting person (F4). The exact total beneficially owned after this sale is not provided here.
- Footnotes of note: F1 (10b5‑1 plan), F2 (weighted‑average price/range and offer to provide per‑price breakdown), F3 (trust holdings), F4 (355,697 RSUs).
Context
The sale was performed under a prearranged 10b5‑1 plan, which is commonly used by insiders to sell shares on a scheduled basis and is typically considered routine rather than a real‑time signal of sentiment. For retail investors, purchases by insiders often carry more direct informational weight than scheduled sales; this filing alone does not indicate a change in CEO confidence or company fundamentals.